NPI: 1013962307 · CHARLOTTE, NC 28270 · Family Medicine Physician · NPI assigned 05/24/2006
Authorized official WALTON, LEEA controls 20+ related entities in our dataset. Read more
| Authorized Official | WALTON, LEEA (RCS MANAGER) |
| NPI Enumeration Date | 05/24/2006 |
Other providers sharing the same authorized official: WALTON, LEEA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 4,877 | $176K |
| 2019 | 3,508 | $179K |
| 2020 | 2,253 | $120K |
| 2021 | 11,525 | $214K |
| 2022 | 26,748 | $254K |
| 2023 | 25,455 | $142K |
| 2024 | 29,294 | $86K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7,177 | 6,425 | $487K |
| 99199 | Unlisted special service, procedure or report | 85,187 | 82,818 | $302K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5,481 | 4,879 | $297K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 779 | 719 | $29K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 778 | 730 | $14K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1,272 | 1,157 | $9K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 61 | 55 | $6K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 150 | 145 | $5K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 37 | 36 | $4K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 28 | 26 | $4K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 54 | 54 | $3K |
| 90686 | 676 | 627 | $2K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 121 | 102 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 29 | 26 | $1K |
| 83036 | Hemoglobin; glycosylated (A1C) | 140 | 126 | $1K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 78 | 39 | $1K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 13 | 12 | $1K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 131 | 119 | $960.37 |
| 90674 | 88 | 81 | $540.55 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 31 | 25 | $528.45 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 12 | 12 | $338.64 |
| 81001 | 51 | 40 | $124.50 | |
| 92551 | 60 | 56 | $18.36 | |
| 99173 | 35 | 32 | $3.06 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 351 | 324 | $0.00 |
| G8541 | Functional outcome assessment using a standardized tool not documented, reason not given | 264 | 240 | $0.00 |
| 90461 | 32 | 32 | $0.00 | |
| 99177 | 14 | 14 | $0.00 | |
| G8432 | Depression screening not documented, reason not given | 68 | 63 | $0.00 |
| G8732 | No documentation of pain assessment, reason not given | 264 | 243 | $0.00 |
| 1036F | 152 | 135 | $0.00 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 29 | 26 | $0.00 |
| G8536 | No documentation of an elder maltreatment screen, reason not given | 17 | 12 | $0.00 |